NCI Community Oncology Research Program - Kansas City (NCORP-KC)
What is the NCORP-KC?
August 1, 2014: The NCI Community Oncology Research Program – Kansas City (NCORP-KC), formerly known as the Kansas City Clinical Oncology Program (KCCOP), has been selected as the recipient of one of 34 Community Site NCORP awards made throughout the United States. An additional 12 awards were made to Minority/Underserved Community sites. The new NCORP designation allows the program to continue to provide patients with access to national clinical trials and cancer care delivery research studies, while allowing patients and their families to remain in their own communities and under the care of their own physicians.
NCORP-KC is a cooperative effort involving seven Kansas City area health care organizations, as well as more than 50 medical oncologists, radiation oncologists, gynecologic oncologists, surgeons, and other specialists. The KCCOP was initially funded by the NCI in 1983 as one of the first community oncology programs and has provided participation opportunities to over 4,200 patients and volunteers in cancer-related studies since its inception. NCORP-KC affiliates with major research centers throughout the nation to bring the benefits of cutting edge cancer research to Kansas City through participation in NCI studies with the Southwest Oncology Group, NRG Oncology, the Alliance for Clinical Trials in Oncology, the University of Rochester Cancer Center, and Wake Forest Comprehensive Cancer Center. In addition, many more studies are available via the Clinical Trials Support Unit of the NCI.
NCORP-KC’s goal is to identify eligible patients to participate in investigational cancer studies designed to determine ways to prevent, control, detect, diagnose and treat cancer. Cancer care delivery research within NCORP-KC focuses on outcomes research, healthcare informatics, behavioral science, rehabilitation and survivorship, palliative care, cellular therapy, and other diverse and multi-level factors that affect access to and quality of care in the community.
For additional information about NCORP-KC, please call 913/948-5588 or email us.
We are deeply privileged to bring the NCI's studies to the Kansas City metro area under the new NCORP mechanism. The designs of new cancer clinical trials help the entire cancer community in accelerating the race towards curing cancer or preventing cancer - in one person or in the entire community.
We look forward to further enhancing the work previously done by the Kansas City CCOP, now NCORP-KC with all individuals who are dedicated to this common mission.
Rakesh Gaur, MD, MPH, FACP
NCORP-KC Principal Investigator